Published in Environ Health Perspect on February 01, 1991
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect (2006) 1.91
In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect (1994) 1.74
Bone lead as a new biologic marker of lead dose: recent findings and implications for public health. Environ Health Perspect (1998) 1.38
Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med (1994) 1.18
Accumulated body burden and endogenous release of lead in employees of a lead smelter. Environ Health Perspect (1997) 1.15
Bone lead measured by X-ray fluorescence: epidemiologic methods. Environ Health Perspect (1995) 1.13
A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect (1995) 1.08
Cumulative lead dose and cognitive function in older adults. Epidemiology (2009) 1.07
Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med (1998) 1.06
Gender and race/ethnicity differences in lead dose biomarkers. Am J Public Health (2008) 1.06
New findings on sources and biokinetics of lead in human breast milk: bone lead can target both nursing infant and fetus. Environ Health Perspect (1998) 0.98
Strategies for epidemiologic studies of lead in bone in occupationally exposed populations. Environ Health Perspect (1991) 0.98
Validation of K-XRF bone lead measurement in young adults. Environ Health Perspect (1995) 0.98
In vivo quantification of lead in bone with a portable x-ray fluorescence system--methodology and feasibility. Phys Med Biol (2011) 0.98
109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood. Occup Environ Med (2000) 0.94
Spatial distribution of the trace elements zinc, strontium and lead in human bone tissue. Bone (2013) 0.94
Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers. Occup Environ Med (1999) 0.94
Bone lead content assessed by L-line x-ray fluorescence in lead-exposed and non-lead-exposed suburban populations in the United States. Proc Natl Acad Sci U S A (1993) 0.91
Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect (2004) 0.83
Effect of lead exposure and ergonomic stressors on peripheral nerve function. Environ Health Perspect (2005) 0.79
Measurements of Strontium Levels in Human Bone In Vivo Using Portable X-ray Fluorescence (XRF). Appl Spectrosc (2017) 0.78
Measurement variability associated with KXRF bone lead measurement in young adults. Environ Health Perspect (2000) 0.77
Bias correction by use of errors-in-variables regression models in studies with K-X-ray fluorescence bone lead measurements. Environ Res (2010) 0.76
Feasibility of a portable X-ray fluorescence device for bone lead measurements of condor bones. Sci Total Environ (2017) 0.75
Theoretical modeling of a portable x-ray tube based KXRF system to measure lead in bone. Physiol Meas (2017) 0.75
In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol (1985) 2.46
In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med (1988) 2.43
Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health (1988) 2.37
An X-ray fluorescence technique for in vivo determination of lead concentration in a bone matrix. Phys Med Biol (1979) 1.59
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. Phys Med Biol (1989) 1.46
In vivo X-ray fluorescence estimation of bone lead concentrations in Queensland adults. Br J Radiol (1984) 1.36
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements. Phys Med Biol (1986) 1.35
Lead in finger-bone analysed in vivo in active and retired lead workers. Am J Ind Med (1984) 1.31
Improvements in the precision of in vivo bone lead measurements. Phys Med Biol (1989) 1.26
Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence. Med Phys (1983) 1.25
X-ray fluorescence analysis of lead in human skeleton in vivo. Scand J Work Environ Health (1976) 1.15
Microprobe analysis of lead in human femur by proton induced X-ray emission (PIXE). Sci Total Environ (1978) 1.12
In vivo measurement of cortical bone lead using polarized x rays. Med Phys (1989) 0.99
Lead in bone. I. Direct analysis for lead in milligram quantities of bone ash by graphite furnace atomic absorption spectroscopy. Am J Clin Pathol (1981) 0.86
In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol (1985) 2.46
In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med (1988) 2.43
Three-dimensional imaging of dislocations in a nanoparticle at atomic resolution. Nature (2013) 2.37
Unexpected mobilisation of lead during cisplatin chemotherapy. Lancet (1986) 1.95
Cadmium fume inhalation and emphysema. Lancet (1988) 1.84
In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health (1993) 1.47
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. Phys Med Biol (1989) 1.46
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements. Phys Med Biol (1986) 1.35
Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics (1992) 1.26
Improvements in the precision of in vivo bone lead measurements. Phys Med Biol (1989) 1.26
Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol (1998) 1.25
Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine. Gastroenterology (1997) 1.22
The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res (2000) 1.11
Kidney effects in long term exposed lead smelter workers. Br J Ind Med (1992) 1.11
Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun (2000) 1.10
New method of serological testing for Mycobacterium avium subsp. paratuberculosis (Johne's disease) by flow cytometry. Foodborne Pathog Dis (2005) 1.08
Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure. Br J Ind Med (1992) 1.07
Molecular profiling reveals prognostically significant subtypes of canine lymphoma. Vet Pathol (2012) 1.03
Renal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations. Lancet (1983) 0.97
In vivo elemental analysis in occupational medicine. Scand J Work Environ Health (1986) 0.97
The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci (2001) 0.96
Chelated lead and bone lead. Scand J Work Environ Health (1992) 0.93
Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. Br J Ind Med (1988) 0.92
Borrelia burgdorferi not detected in widespread Ixodes scapularis (Acari: Ixodidae) collected from white-tailed deer in Tennessee. J Med Entomol (2012) 0.91
Longitudinal studies of exposure to cadmium. Br J Ind Med (1992) 0.86
An improved in vivo neutron activation system for measuring kidney cadmium. Phys Med Biol (1990) 0.84
Genetic segregation analysis of red blood cell (RBC) histamine N-methyltransferase (HNMT) activity. Genet Epidemiol (1993) 0.84
Effect of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels. Hum Exp Toxicol (1990) 0.82
Direct measurement of dopamine O-sulfate in plasma and cerebrospinal fluid. J Chromatogr (1987) 0.78
Design studies related to an in vivo neutron activation analysis facility for measuring total body nitrogen. Phys Med Biol (1992) 0.78
Measurements of trace elements in vivo. Basic Life Sci (1990) 0.78
Monte Carlo modelling of in vivo x-ray fluorescence of lead in the kidney. Phys Med Biol (1991) 0.78
In vivo neutron activation analysis of organ cadmium burdens. Referent levels in liver and kidney and the impact of smoking. Biol Trace Elem Res (1991) 0.77
Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors. Agents Actions (1993) 0.77
Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors. Vet Comp Oncol (2013) 0.77
Miao et al. reply. Nature (2013) 0.75
In-vivo and in-vitro measurements of lead and cadmium. Biol Trace Elem Res (1987) 0.75
In-phantom neutron fluence measurements in the orthogonal Birmingham boron neutron capture therapy beam. Med Phys (1998) 0.75
A pilot study using 99mTc to measure lead and platinum in the human kidney. Nucl Med Biol (1993) 0.75
Multiple therapies for vaginal bleeding secondary to large uterine myomas. Int J Gynaecol Obstet (1991) 0.75
Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci (1986) 0.75
The use of multiple parameters to characterize cadmium-induced renal dysfunction resulting from occupational exposure. Environ Res (1994) 0.75
Fast neutron spectrum measurements in anthropomorphic phantoms using an NE213 scintillation spectrometer. Phys Med Biol (1987) 0.75
In situ neutron spectrometry to 60 MeV in a water phantom exposed to a cancer therapy beam. Phys Med Biol (1991) 0.75
Changes in the rate of cortical epileptiform activity by increased intragastric pressure in cats. Exp Neurol (1981) 0.75
Feasibility studies in the in vivo measurement of iron in synovial membrane. Basic Life Sci (1990) 0.75
On the in vivo measurement of mercury using neutron capture and x-ray fluorescence. Int J Appl Radiat Isot (1982) 0.75